Picrasidine I

• Description:

  Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  240.3

• Molecular Formula:

  C14H12N2O2

• Notes:

  Research use only, not for human use.

• Receptor:

  ——

• CAS Number:

  100234-59-1